Honz Pharmaceutical (300086.SZ) appoints Li Jing as the Chief Financial Officer.
Kangzhi Pharmaceutical (300086.SZ) announcement, the company's board of directors has agreed that Han Dingfu will no longer serve as the company's chief financial officer...
Honz Pharmaceutical (300086.SZ) announced that the Board of Directors has agreed to remove Han Dingfu from the position of Chief Financial Officer, but he will continue to serve as Director of Internal Control and Compliance. The Board of Directors has also approved the appointment of Li Jing as the new Chief Financial Officer, with a term starting from the date of approval at this Board meeting until the end of the sixth session of the Board of Directors.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
